Literature DB >> 15237451

Multiple gene differential expression patterns in human ischemic liver: safe limit of warm ischemic time.

Qi-Ping Lu1, Ting-Jia Cao, Zhi-Yong Zhang, Wei Liu.   

Abstract

AIM: To investigate the multiple gene differential expression patterns in human ischemic liver and to produce the evidence about the hepatic ischemic safety time.
METHODS: The responses of cells to hepatic ischemia and hypoxia at hepatic ischemia were analyzed by cDNA microarrary representing 4 000 different human genes containing 200 apoptotic correlative genes.
RESULTS: There were lower or normal expression levels of apoptotic correlative genes during the periods of hepatic ischemia for 0-15 min, the maintenance homostatic genes were expressed significantly higher at the same time. But at the hepatic ischemia for 30 min, the expression levels of maintenance homeostatic genes were down-regulated, the expressions of many apoptotic correlative genes and nuclear transcription factors were activated and up-regulated.
CONCLUSION: HIF-1, APAF-1, PCDC10, FBX5, DFF40, DFFA XIAP, survivin may be regarded as the signal genes to judge the degree of hepatic ischemic-hypoxic injure, and the apoptotic liver cell injury due to ischemia in different time limits. The safe limit of human hepatic warm ischemic time appears to be generally less then 30 min.

Entities:  

Mesh:

Year:  2004        PMID: 15237451      PMCID: PMC4572350          DOI: 10.3748/wjg.v10.i14.2130

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  20 in total

1.  Safety of hemihepatic vascular occlusion during resection of the liver.

Authors:  M Makuuchi; T Mori; P Gunvén; S Yamazaki; H Hasegawa
Journal:  Surg Gynecol Obstet       Date:  1987-02

Review 2.  [Anatomical and atypical liver resections].

Authors:  J Scheele
Journal:  Chirurg       Date:  2001-02       Impact factor: 0.955

3.  TRAF6-NF-kappaB pathway is essential for interleukin-1-induced TLR2 expression and its functional response to TLR2 ligand in murine hepatocytes.

Authors:  Takayuki Matsumura; Takahiro Degawa; Takemasa Takii; Hidetoshi Hayashi; Takashi Okamoto; Jun-ichiro Inoue; Kikuo Onozaki
Journal:  Immunology       Date:  2003-05       Impact factor: 7.397

4.  Bcl-XL interacts with Apaf-1 and inhibits Apaf-1-dependent caspase-9 activation.

Authors:  Y Hu; M A Benedict; D Wu; N Inohara; G Núñez
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-14       Impact factor: 11.205

Review 5.  Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury.

Authors:  Hartmut Jaeschke; John J Lemasters
Journal:  Gastroenterology       Date:  2003-10       Impact factor: 22.682

6.  [Clinical studies on changes in serum transaminase, lactate dehydrogenase, total bilirubin and alkaline phosphatase levels after hepatectomy with and without the hemihepatic vascular occlusion technique].

Authors:  T Mori; M Makuuchi; J Kobayashi; M Sukigara; S Yamasaki; H Hasegawa
Journal:  Nihon Geka Gakkai Zasshi       Date:  1985-07

7.  Antiapoptotic and protective effects of roscovitine on ischemia-reperfusion injury of the rat liver.

Authors:  Serdar Topaloglu; Osman Abbasoglu; Ayse Ayhan; Cenk Sokmensuer; Kamer Kilinc
Journal:  Liver Int       Date:  2003-08       Impact factor: 5.828

8.  Identification of TIFA as an adapter protein that links tumor necrosis factor receptor-associated factor 6 (TRAF6) to interleukin-1 (IL-1) receptor-associated kinase-1 (IRAK-1) in IL-1 receptor signaling.

Authors:  Hiroshi Takatsuna; Hiroki Kato; Jin Gohda; Taishin Akiyama; Ayaka Moriya; Yoshinari Okamoto; Yuriko Yamagata; Masami Otsuka; Kazuo Umezawa; Kentaro Semba; Jun-Ichiro Inoue
Journal:  J Biol Chem       Date:  2003-02-03       Impact factor: 5.157

9.  Multiple-system organ damage resulting from prolonged hepatic inflow interruption.

Authors:  D L Liu; B Jeppsson; C H Hakansson; R Odselius
Journal:  Arch Surg       Date:  1996-04

Review 10.  Death receptor activation-induced hepatocyte apoptosis and liver injury.

Authors:  Xiao-Ming Yin; Wen-Xing Ding
Journal:  Curr Mol Med       Date:  2003-09       Impact factor: 2.222

View more
  6 in total

Review 1.  Role of the Survivin gene in pathophysiology.

Authors:  Fengzhi Li; Michael G Brattain
Journal:  Am J Pathol       Date:  2006-07       Impact factor: 4.307

2.  Resection of abdominal solid organs using high-intensity focused ultrasound.

Authors:  Vesna Zderic; Grant E O'Keefe; Jessica L Foley; Shahram Vaezy
Journal:  Ultrasound Med Biol       Date:  2007-05-11       Impact factor: 2.998

3.  Hyperglycemia attenuates angiogenic capability of survivin in endothelial cells.

Authors:  Qinhui Song; Xiaojin An; Dongmei Li; Neel R Sodha; Munir Boodhwani; Ye Tian; Frank W Sellke; Jian Li
Journal:  Microvasc Res       Date:  2009-08-27       Impact factor: 3.514

4.  Transplant tourism to China: the impact on domestic patient-care decisions.

Authors:  Scott W Biggins; Kiran Bambha; Norah Terrault; John Inadomi; John P Roberts; Nathan Bass
Journal:  Clin Transplant       Date:  2009-01-10       Impact factor: 2.863

5.  Circulating Survivin Levels in Obstructive Sleep Apnoea.

Authors:  Laszlo Kunos; Peter Horvath; Adrian Kis; David Laszlo Tarnoki; Adam Domonkos Tarnoki; Zsofia Lazar; Andras Bikov
Journal:  Lung       Date:  2018-05-08       Impact factor: 2.584

6.  Inhibition of chymotrypsin-like activity of the proteasome by ixazomib prevents mitochondrial dysfunction during myocardial ischemia.

Authors:  Gina Sánchez; Stefanie Chalmers; Xavier Ahumada; Luis Montecinos; Ivonne Olmedo; Veronica Eisner; Ana Riveros; Marcelo J Kogan; Sergio Lavandero; Zully Pedrozo; Paulina Donoso
Journal:  PLoS One       Date:  2020-05-26       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.